Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to look at kidney function and hormonal function in patients with a history of heart failure and kidney dysfunction, and to see how the use of a new drug, ANX-042, affects those functions.
Epistemonikos ID: ab3e44510ea1ad3d6d38d209b1c6d683919ee5c1
First added on: May 20, 2024